Skip to content
ShapeTX
  • About
  • Careers
  • News & Blog
  • Contact

Media Mentions

23 Top Biotech Startups According to VCs (Business Insider, July 28, 2022)

23 Top Biotech Startups According to VCs (Business Insider, July 28, 2022)

Fierce Biotech’s 2022 Fierce 15 (Fierce Biotech, September 12, 2022)

Fierce Biotech’s 2022 Fierce 15 (Fierce Biotech, September 12, 2022)

Pushing Beyond Gene Editing Limits with Programmable RNA Medicines (Biospace, June 13, 2022)

Pushing Beyond Gene Editing Limits with Programmable RNA Medicines (Biospace, June 13, 2022)

Base Editing Marches on the Clinic (Nature Biotechnology, May 9, 2022)

Base Editing Marches on the Clinic (Nature Biotechnology, May 9, 2022)

Two small biotechs hope that gene therapy will be the future of Alzheimer’s disease treatment.  Here’s what we know so far. (Business Insider, January 25, 2022)

Two small biotechs hope that gene therapy will be the future of Alzheimer’s disease treatment. Here’s what we know so far. (Business Insider, January 25, 2022)

RNA Editing Seeks Its Place in the Gene Editing World (Timmerman  Report, January 5, 2022)

RNA Editing Seeks Its Place in the Gene Editing World (Timmerman Report, January 5, 2022)

In editing RNA, researchers see endless possibilities (The Scientist, December 1, 2021)

In editing RNA, researchers see endless possibilities (The Scientist, December 1, 2021)

RNA-editing race intensifies as big pharma buys in (Chemical & Engineering News, October 23, 2021)

RNA-editing race intensifies as big pharma buys in (Chemical & Engineering News, October 23, 2021)

tRNA therapies could help restore proteins lost in translation (Chemical & Engineering News, September 19, 2021)

tRNA therapies could help restore proteins lost in translation (Chemical & Engineering News, September 19, 2021)

The Point of Base Editors:  Correcting Point Mutations (Genetic Engineering & Biotechnology News (GEN), September 1, 2021)

The Point of Base Editors: Correcting Point Mutations (Genetic Engineering & Biotechnology News (GEN), September 1, 2021)

Shape Therapeutics raises $112M in bid to make RNA editing – and a whole lot else – a reality (Endpoints, July 15, 2021)

Shape Therapeutics raises $112M in bid to make RNA editing – and a whole lot else – a reality (Endpoints, July 15, 2021)

The future of programmable RNA medicine

About Careers News & Blog Contact
Seattle

700 Dexter Ave N
Seattle, WA 98109

Boston

17 Drydock Ave
Boston, MA 02210

© 2025 Shape TX

Privacy Policy
© 2025 ShapeTX • Built with GeneratePress

The future of programmable RNA medicine

  • About
  • Careers
  • News & Blog
  • Contact